AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic 'RelieVRx' and Announces Three-month Durability Study Results
Publication/Creation DateMarch 22 2022
Description"LOS ANGELES, March 22, 2022 /PRNewswire/ -- AppliedVR, a pioneer advancing the next generation of immersive therapeutics, today announced a new name for its flagship virtual reality (VR) therapeutic. EaseVRx, which was granted De Novo approval by the FDA last November for chronic lower back pain, will now be known as RelieVRx. The renaming followed extensive conversations with chronic pain specialists, healthcare professionals and patients who reinforced the outcomes and pain relief delivered by the product."
Date archivedMay 5 2022
Last editedMay 5 2022
How to cite this entry
AppliedVR Inc., Sam Moore. (March 22 2022). "AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic 'RelieVRx' and Announces Three-month Durability Study Results". PRNewswire. Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/5733